SecBot SecBot
8-K ·Filed Sep 30, 2026

BNTC

Benitec Biopharma Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed25d 23h ago SEC0001193125-26-409052
8-K material event: Items 4.01
Actionable Insight • Neutral

Monitor the next 10-Q or 10-K for any restatements or material weakness disclosures that may surface under the new auditor's review. No immediate catalyst.

DirectionNeutral
Confidencehigh
Horizonmonths
Latest settled — T+5d
BNTC ▼ -8.66% at T+5d
NEUTRAL call -8.66% · α vs SPY -9.96% · entry $9.58 → $8.75
Next anchor: T+20d tomorrow
Latest observation: T+16 -3.80% FF3 residual α
Entry = T+0 close
Sep 30, 2026
via day close
T+1d
-6.26%
call -6.26% · α -7.00%
$8.98
settled 25d ago
T+5d
-8.66%
call -8.66% · α -9.96%
$8.75
settled 19d ago
T+20d
Pending
tomorrow
T+60d
Pending
in 8w

Price Chart

Loading chart...

Executive Summary

Benitec Biopharma filed an 8-K confirming the engagement of Ernst & Young (EY) as its independent auditor for FY2027, following EY's completion of client acceptance procedures. This is a routine administrative step formalizing a previously disclosed auditor change, with no reported disagreements or material weaknesses.

Key Facts

  • EY completed client acceptance procedures on September 28, 2026.
  • Engagement letter executed on September 29, 2026, for FY2027 audit.
  • No disagreements or reportable conditions disclosed between the company and former auditor.
  • Previous auditor change was disclosed in an 8-K filed on September 24, 2026.

Financial Impact

No financial impact disclosed; auditor change is administrative.

Risk Factors

  • Auditor changes can signal underlying accounting issues, though none are indicated here.
  • Delays in audit completion if EY identifies new issues during FY2027 audit.

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-409052
Document: 0001193125-26-409052-index-headers.html0001193125-26-409052
Document: 0001193125-26-409052-index.html0001193125-26-409052
Document: 0001193125-26-409052.txt0001193125-26-409052
11 reports for BNTC
Performance horizon
67% Hit rate @ T+1 2 of 3 directional calls Went positive at some point 3 of 3 best @ T+20▲ +17.44%Sep 22, 2026
Filters
Rows
Reports for BNTC — sortable, filterable
TypeNow
Oct 20, 2026
5d ago
DEFA14A
NEUTRAL ★ 2/10
$8.50 $8.82▲ +3.76%▲ +4.95%$8.58 (+0.94%)
Oct 20, 2026
5d ago
DEF 14A
NEUTRAL ★ 4/10
$8.50 $8.82▲ +3.76%▲ +4.95%$8.58 (+0.94%)
Oct 5, 2026
21d ago
8-K
NEUTRAL ★ 4/10
$9.23 $9.00▼ −2.49%▼ −3.04%$8.58 (−7.04%)
Sep 30, 2026
25d ago
8-K
NEUTRAL ★ 3/10
$9.58 $8.98▼ −6.26%▼ −7.00%$8.58 (−10.44%)
Sep 22, 2026
4w ago
EFFECT
BEARISH ★ 5/10
$10.95 $9.83▲ +10.23%▲ +9.51%$8.58 (+21.64%)
Sep 14, 2026
5w ago
Press Release
NEUTRAL ★ 5/10
$11.05 $11.04▼ −0.09%▲ +0.35%$8.58 (−22.35%)
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 3/10
$11.05 $11.18▲ +1.18%▲ +0.64%$8.58 (−22.35%)
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 3/10
$11.05 $11.18▲ +1.18%▲ +0.64%$8.58 (−22.35%)
May 14, 2026
23w ago
8-K
NEUTRAL ★ 4/10
$11.85 $11.49▼ −3.04%▼ −1.81%$8.58 (−27.59%)
May 14, 2026
23w ago
Press Release
BULLISH ★ 6/10
$11.85 $11.49▼ −3.04%▼ −1.81%$8.58 (−27.59%)
Showing 10 of 11

US Market Status

Market Open — Closes in 2m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 30, 2026